Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeEmergent BioSolutions Inc.

      Emergent BioSolutions Inc.

      Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors
      Health

      Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors

      July 6, 2022
      Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
      Health

      Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate

      June 24, 2022

       

      LATEST NEWS

      • Investing News Amazon’s Market Challenges Explained
      • Investing News GE HealthCare Stock Outlook: Bullish Signals?
      • Investing News Accenture Stock Outlook: Bullish or Bearish?
      • Investing News Teradyne Stock Forecast: Rise or Reversal?
      • Investing News Qualcomm Stock Dip Buy: Oversold or Opportunity?

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026